Drug Shortage Report for TEVA-QUININE
Report ID | 95393 |
Drug Identification Number | 00021016 |
Brand name | TEVA-QUININE |
Common or Proper name | QUININE CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | QUININE SULFATE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | P01BC |
ATC description | ANTIMALARIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-10-03 |
Estimated end date | |
Actual end date | 2020-01-23 |
Shortage status | Resolved |
Updated date | 2020-01-24 |
Company comments | Pack size is discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-01-24 | French | Compare |
v4 | 2020-01-24 | English | Compare |
v3 | 2019-10-04 | English | Compare |
v2 | 2019-10-03 | French | Compare |
v1 | 2019-10-03 | English | Compare |
Showing 1 to 5 of 5